INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 2 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $0 | – | 81 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 81 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 81 | -99.8% | 0.00% | – |
| Q2 2017 | $111,000 | +258.1% | 41,538 | +429.9% | 0.00% | – |
| Q1 2017 | $31,000 | -61.2% | 7,839 | -59.6% | 0.00% | – |
| Q4 2016 | $80,000 | +53.8% | 19,387 | +151.9% | 0.00% | – |
| Q3 2016 | $52,000 | +85.7% | 7,696 | +56.4% | 0.00% | – |
| Q2 2016 | $28,000 | -89.0% | 4,921 | -86.6% | 0.00% | – |
| Q1 2016 | $255,000 | +454.3% | 36,604 | +457.8% | 0.00% | – |
| Q4 2015 | $46,000 | -27.0% | 6,562 | -10.3% | 0.00% | – |
| Q3 2015 | $63,000 | -53.3% | 7,319 | -12.7% | 0.00% | – |
| Q2 2015 | $135,000 | – | 8,383 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IMS Capital Management | 246,966 | $1,778,000 | 2.19% |
| WELCH & FORBES LLC | 902,286 | $6,496,000 | 0.21% |
| Alambic Investment Management, L.P. | 25,100 | $181,000 | 0.11% |
| EMERSON INVESTMENT MANAGEMENT, LLC | 74,175 | $534,000 | 0.10% |
| Hayek Kallen Investment Management | 10,965 | $79,000 | 0.06% |
| Yellowstone Partners, LLC | 10,045 | $72,000 | 0.03% |
| Ausdal Financial Partners, Inc. | 7,750 | $56,000 | 0.03% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 29,647 | $213,000 | 0.03% |
| GROUP ONE TRADING, L.P. | 61,856 | $445,000 | 0.01% |
| Cambridge Investment Research Advisors, Inc. | 10,500 | $76,000 | 0.00% |